Ryan Isola is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he focuses on corporate finance, securities law and corporate governance matters. He advises a diverse range of public and private companies in equity offerings, secured and unsecured lending transactions, as well as convertible, high-yield, and investment-grade notes offerings.
Ryan has experience advising issuers with repurchasing outstanding shares of common stock or debt securities, including through private market repurchases or exchange offers. He has experience advising clients on complex derivative transactions such as capped calls, tax-integrated bond hedge and warrant transactions. Ryan also advises borrowers in debt financing transactions including venture debt, revolving credit facilities and syndicated term loans.
Ryan Isola is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he focuses on corporate finance, securities law and corporate governance matters. He advises a diverse range of public and private companies in equity offerings, secured and unsecured lending transactions, as well as convertible, high-yield, and investment-grade notes offerings.
Ryan has experience advising issuers with repurchasing outstanding shares of common stock or debt securities, including through private market repurchases or exchange offers. He has experience advising clients on complex derivative transactions such as capped calls, tax-integrated bond hedge and warrant transactions. Ryan also advises borrowers in debt financing transactions including venture debt, revolving credit facilities and syndicated term loans.
- J.D., UC Davis School of LawOrder of the Coif; Dean’s Merit Scholar; Articles Editor, UC Davis Law Review
- B.A., Political Science and Psychology, University of California, Los Angeles
- State Bar of California
- J.D., UC Davis School of LawOrder of the Coif; Dean’s Merit Scholar; Articles Editor, UC Davis Law Review
- B.A., Political Science and Psychology, University of California, Los Angeles
- State Bar of California
The financing will strengthen Neptune Medical as a gastrointestinal-focused company expanding into robotics for GI disease, as evidenced by the recent appointment of medical robotics pioneer Dr. Fred Moll as chairman of the company’s board.
Neptune Medical also announced the successful spinout of its subsidiary, Jupiter Endovascular, which is developing a new class of endovascular procedures to bring the precision and control of direct surgical access to catheter-based interventions. Wilson Sonsini will represent Jupiter Endovascular moving forward.
The Wilson Sonsini team that advised Neptune Medical on the Series D financing included James Huie, Brian Appel, MJ Han, and Ryan Isola.
For more information, please see Neptune Medical’s news release. Additional coverage is available in Fierce Biotech.
- Privacy Policy
- Terms of Use
- Accessibility